The RDN procedure, just like any medical procedure, has some risks. However, clinical studies show that these risks and side effects are rare.
The safety and effectiveness of this blood pressure procedure have not been evaluated in patients who are pregnant, nursing young babies, or those below the ages of 18 years old.
Careful consideration should be given to use of this RDN procedure in patients with aortic grafts or who have received a renal stent in the last three months.
If you have an implantable pacemaker or Implantable Cardioverter/Defibrillator (ICD), your doctor will need to take precautions prior to your procedure, as these devices can be adversely affected by the radiofrequencies used during the procedure. Your doctor will discuss the necessary steps that need to be taken with your pacemaker or ICD before undergoing the RDN procedure.
You should not undergo the RDN procedure if:
- You have an allergy or suspected allergy to nitinol.
- You are unable to tolerate atropine, nitroglycerine, or systemic anticoagulation medication.
- A reduction in your blood pressure would be detrimental to your health.
- Your doctor determines that your arteries are too narrow or too wide to insert the catheter.
Your heart rate may decrease during the procedure. If this happens, your doctor will administer medication to increase your heart rate.
Intervention risks include:
Death, cardiopulmonary arrest, heart rhythm disturbances including bradycardia, formation of blood clots and/or embolism (which may result in ischemic events such as myocardial infarction, pulmonary embolism, stroke, kidney damage, or peripheral ischemia), retroperitoneal hematoma, hematoma, bruising, bleeding, arterial damage, arterial spasm, arterial stenosis, arterial dissection or pseudoaneurysm, AV fistula, pain, skin burns, and thermal injury to the vasculature or other structures from energy application.
Contrast agents, narcotics, anxiolytics, other pain medications and anti-vasospasm agents are also commonly used during the procedure or after the procedure; use of these agents is associated with known risks.
Other treatment risks include:
Proteinuria, hematuria, electrolyte disturbances, worsening renal function, hypotension, hypertension, orthostatic hypotension, hypotension causing end organ hypoperfusion, nausea, and vomiting.